Angiogenic Inflammatory Biomarkers in Juvenile Idiopathic Arthritis
Status: Recruiting
Location: See location...
Intervention Type: Biological
Study Type: Observational
SUMMARY
The aim of the study is to determine whether serum inflammatory angiogenic markers (eg, semaphorins, CCN1) predict severity of juvenile idiopathic arthritis defined by structural progression and/or therapeutic escalation.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 16
Healthy Volunteers: f
View:
• Greater than or equal to 16 years-old
• Diagnosis of Juvenile Idiopathic Arthritis with specialized follow up in Rheumatology at Cochin Hospital
• No-opposition to the research
• Patient with health insurance
• Mastery of the French language
Locations
Other Locations
France
Rheumatology Department, Cochin Hospital
RECRUITING
Paris
Contact Information
Primary
Yannick ALLANORE, PD, PhD
yannick.allanore@aphp.fr
0033158412563
Backup
Marie BENHAMMANI-GODARD
marie.godard@aphp.fr
+33 1 58411190
Time Frame
Start Date: 2023-03-13
Estimated Completion Date: 2030-03
Participants
Target number of participants: 300
Treatments
Juvenile Idiopathic Arthritis
Patients seen in a specialized rheumatology consultation for the management of juvenile idiopathic arthritis in an adult service, after information and collection of their non-opposition.
Related Therapeutic Areas
Sponsors
Collaborators: URC-CIC Paris Descartes Necker Cochin
Leads: Assistance Publique - Hôpitaux de Paris